Position in NUVB
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,244,100
-$4,225,980 QoQ
Shares Held
290,000
-52.5% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACT CAPITAL MANAGEMENT, LLC holds $76,499,907 across 26 Biotechnology names. NUVB ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
60,477 | $15,622,418 | |
| 2 | CELC |
Celcuity Inc.
|
91,675 | $10,463,784 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
249,025 | $8,272,610 | |
| 4 | ABVX |
Abivax S.A.
|
70,900 | $7,894,715 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
209,300 | $6,810,622 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
82,500 | $5,172,750 | |
| 7 | NKTR |
Nektar Therapeutics
|
70,900 | $5,101,255 | |
| 8 | CYTK |
Cytokinetics Inc
|
64,500 | $4,251,195 |
All Filings in NUVB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,244,100 | 290,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,470,080 | 610,500 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||